3Khurana R, Simons M, Martin JF, et al. Role of angiogenesis in cardiovascular disease : a critical appraisal [ J ]. Circulation, 2005, 112(12) :1813 - 1824.
4Herve MA, Meduri G, Petit FG, et al. Regulation of the vascular endothelial growth factor (VEGF) receptor Flk-1/KDR by estradiol through VEGF in uterus[J]. J Endocrinol, 2006, 188(1 ) :91 -99.
8Saijonmaa O, Nyman T, Stewen P, et al. Atorvastatin completely inhibits VEGF-induced ACE upregulation in human endothelial cells [J]. Am J Physiol Heart Circ Physiol, 2004, 286(6): H2096 - H2102,
9Sven W, Ulrich L, Kirsten M, et al. Cellular antioxidant effects of atorvatatin in vitro and in vivo[J]. Aterioscler Thromb Vasc Biol,2002, 22: 300-305.
10Seljeflot I, Tonsatd S, Hjermann I, et al. Reduced expression of endothelial cell markers after I year treatment with simvastatin and atorvastatin in patients with coronary heart disease [J]. Atherosclerosis,2002, 162(1): 179-185.
7Dlyan F, Rottx D, Brahimi-Horn MC, et al. The oxygen sensor faetor-inhlbiting hypoxia-inducilde faetor-1 controls expression of distirt geres through the bifuttimal trnserlptioal eharaete of hvpoxia-indueible factor-1 alpha[J].Caneer Res, 2006, 66 ( 7 ) : 3688 - 3699.
8Llu K, Tian M, Raval RR, et al. Target gene selectiitv of hy poxia-inducihle factor-alpha in renal cancer cells is conveyed by posl-DNA-binding mechanisms [ J ]. Br J Cancer, 2007, 96 ( 8 ) : 1284 - 1292.
9Wang V, Davis DA, ttaque M, et al. Differential Gene up-regula- tion by Hypoxia-indueihle Faetor-I alpha and Hpnxia-indueible Faetor-2alpha in HEK293Teells [ J ]. Cancer Re.s, 2005, 65 ( 8 ) :3299 - 3306.
10Brahimi-Horn MC, Pouyssegur J. The hypoxia-inducible factor and tumor progression along the angiogenie pathway [J].Int Rer Cytol, 2005, 242:157-213.
